Clinical trial
A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool in Prescribing Antidepressant Medication for the Treatment of Patients Diagnosed With Major Depressive Disorder
NCT04031157 is registered in ClinicalTrials.gov with Taliaz Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool in Prescribing Antidepressant Medication for the Treatment of Patients Diagnosed With Major Depressive Disorder
- Lead sponsor
- Taliaz Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2018
- Completion date
- December 31, 2020
- Enrollment
- 220 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.